TD Asset Management’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $43.6M | Buy |
|
|||||
|
2025
Q1 | $33.2M | Buy |
|
|||||
|
2024
Q4 | $36.7M | Sell |
|
|||||
|
2024
Q3 | $44.6M | Buy |
|
|||||
|
2024
Q2 | $45.4M | Buy |
|
|||||
|
2024
Q1 | $38.9M | Sell |
|
|||||
|
2023
Q4 | $48.4M | Buy |
|
|||||
|
2023
Q3 | $40.8M | Buy |
|
|||||
|
2023
Q2 | $32.2M | Sell |
|
|||||
|
2023
Q1 | $29.2M | Buy |
|
|||||
|
2022
Q4 | $29.4M | Sell |
|
|||||
|
2022
Q3 | $35.6M | Buy |
|
|||||
|
2022
Q2 | $29.8M | Sell |
|
|||||
|
2022
Q1 | $30.4M | Buy |
|
|||||
|
2021
Q4 | $22.6M | Buy |
|
|||||
|
2021
Q3 | $14.2M | Buy |
|
|||||
|
2021
Q2 | $15.7M | Sell |
|
|||||
|
2021
Q1 | $19.1M | Buy |
|
|||||
|
2020
Q4 | $21.8M | Buy |
|
|||||
|
2020
Q3 | $13.3M | Buy |
|
|||||
|
2020
Q2 | $12.2M | Buy |
|
|||||
|
2020
Q1 | $4.53M | Buy |
|
|||||
|
2019
Q4 | $2.53M | Sell |
|
|||||
|
2019
Q3 | $2.82M | Sell |
|
|||||
|
2019
Q2 | $3.13M | Sell |
|
|||||
|
2019
Q1 | $5.8M | Buy |
|
|||||
|
2018
Q4 | $1.16M | Buy |
|
|||||
|
2018
Q3 | $1.01M | Sell |
|
|||||
|
2018
Q2 | $900K | Sell |
|
|||||
|
2018
Q1 | $974K | Sell |
|
|||||
|
2017
Q4 | $1.21M | Buy |
|
|||||
|
2017
Q3 | $903K | Sell |
|
|||||
|
2017
Q2 | $956K | Sell |
|
|||||
|
2017
Q1 | $1.29M | Sell |
|
|||||
|
2016
Q4 | $1.61M | Buy |
|
|||||
|
2016
Q3 | $355K | Sell |
|
|||||
|
2016
Q2 | $469K | Buy |
|
|||||
|
2016
Q1 | $749K | Hold |
|
|||||
|
2015
Q4 | $1.15M | Buy |
|
|||||
|
2015
Q3 | $663K | Hold |
|
|||||
|
2015
Q2 | $944K | Buy |
|
|||||
|
2015
Q1 | $961K | Sell |
|
|||||
|
2014
Q4 | $3.38M | Buy |
|
|||||
|
2014
Q3 | $2.09M | Buy |
|
|||||
|
2014
Q2 | $1.82M | Sell |
|
|||||
|
2014
Q1 | $3.08M | Buy |
|
|||||
|
2013
Q4 | $2.82M | Buy |
|
|||||
|
2013
Q3 | $2.52M | Sell |
|
|||||
|
2013
Q2 | $1.94M | Buy |
|